• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.

广告
第一作者: Shambavi,Richard
第一单位: Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA.
作者单位: Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA. [1] General Hospital Evangelismos, Athens, Greece. [2] Institute of Blood Pathology & Transfusion Medicine of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine. [3] Charles University and General Hospital, Prague, Czech Republic. [4] Clinic of Internal Medicine -Hematology and Oncology, University Hospital Brno, Brno, Czech Republic. [5] National Cancer Institute Ukraine, Kiev, Ukraine. [6] School of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. [7] Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine. [8] Imperial College London, London, UK. [9] Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France. [10] City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine. [11] Department of Hemato-oncology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic. [12] Kings College Hospital NHS Foundation Trust, London, UK. [13] Nil Ratan Sircar Medical College and Hospital, Kolkata, India. [14] State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India. [15] Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. [16] University Hospitals of Leicester NHS Trust, Leicester, UK. [17] Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky, USA. [18] University of Melbourne, St. Vincent's Hospital, Melbourne, Victoria, Australia. [19] University Hospital, Hotel-Dieu, Nantes, France. [20] Baylor University Medical Center, Dallas, Texas, USA. [21] University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA. [22] Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA. [23] University of Calgary, Charbonneau Cancer Research Institute, Calgary, Alberta, Canada. [24] CHU Lille Service des Maladies du Sang F-59000, Lille, France. [25] Hospital Universitario de Salamanca, Salamanca, Spain. [26] Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy. [27] Karyopharm Therapeutics Inc., Newton, Massachusetts, USA. [28] Medical University of Silesia, Katowice, Poland. [29] Dana Farber Cancer Institute, Boston, Massachusetts, USA. [30]
DOI 10.1002/ajh.26261
PMID 34062004
发布时间 2021-09-29
提交
  • 浏览5
American journal of hematology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷